Hawkins Richard J — SEC insider filings

SEC reporting owner CIK 1307632. 34 insider filings on record with FilingPulse; latest filed 2026-10-01.

Transaction summary — filings shown

Covers all 34 filings on record, filed 2020-12-17 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Savara Inc (SVRA)Director101 leg · 48,225 sh · $98,5721 leg · 8,000 sh · $26,56914
LUMOS PHARMA, INC. (LUMO)Chief Executive Officer, Director114 legs · 4,469 sh · $39,259—23
CERENOME, INC. (CNSY)Director134 legs · 15,188 sh · $25,508—14

Insider filings — Hawkins Richard J

FiledFormIssuerReported transactionsSource
2026-10-014CERENOME, INC. (CNSY)Option exercise (M): 921 @ $0 · Option exercise (M): 921 (derivative) @ $0EDGAR
2026-07-014PLUS THERAPEUTICS, INC. (PSTV)Option exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-05-184PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0EDGAR
2025-12-114Savara Inc (SVRA)Grant/award (A): 40,000 @ $0EDGAR
2025-11-174Savara Inc (SVRA)Option exercise (M): 5,860 @ $1.46 · Option exercise (M): 5,860 (derivative) @ $0EDGAR
2025-08-154PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 397,794 (derivative) @ $0EDGAR
2025-06-234Savara Inc (SVRA)Purchase (P): 48,225 @ $2.04EDGAR
2025-02-204PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 40,122 (derivative) @ $0EDGAR
2024-12-164Savara Inc (SVRA)Grant/award (A): 40,000 @ $0 · Sale (S): 8,000 @ $3.32EDGAR
2024-12-134LUMOS PHARMA, INC. (LUMO)Disposition to issuer (D): 753,093 · Disposition to issuer (D): 4,469 · Disposition to issuer (D): 19,624 (derivative) · Disposition to issuer (D): 35,400 (derivative) · Disposition to issuer (D): 35,400 (derivative) · Disposition to issuer (D): 135,000 (derivative) · +2 moreEDGAR
2024-09-174PLUS THERAPEUTICS, INC. (PSTV)Purchase (P): 4,000 @ $1.50EDGAR
2024-09-164PLUS THERAPEUTICS, INC. (PSTV)Purchase (P): 6,285 @ $1.35EDGAR
2024-09-124PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 3,650 (derivative) @ $0EDGAR
2024-05-104PLUS THERAPEUTICS, INC. (PSTV)Purchase (P): 4,902 @ $2.04 · Grant/award (A): 9,804 (derivative) @ $0EDGAR
2024-04-034LUMOS PHARMA, INC. (LUMO)Grant/award (A): 4,500 @ $2.84 · Tax withholding (F): 1,522 @ $2.84 · Grant/award (A): 35,400 (derivative) @ $0EDGAR
2024-02-264PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 2,250 (derivative) @ $0EDGAR
2024-02-054LUMOS PHARMA, INC. (LUMO)Tax withholding (F): 690 @ $3.01EDGAR
2023-12-154Savara Inc (SVRA)Grant/award (A): 22,500 @ $0EDGAR
2023-12-124Savara Inc (SVRA)Option exercise (M): 10,841 @ $0.82 · Option exercise (M): 10,841 (derivative) @ $0EDGAR
2023-04-044LUMOS PHARMA, INC. (LUMO)Tax withholding (F): 1,522 @ $3.31EDGAR
2023-03-064PLUS THERAPEUTICS, INC. (PSTV)Purchase (P): 1 @ $1,000EDGAR
2023-02-174PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 20,182 (derivative) @ $0EDGAR
2023-02-034LUMOS PHARMA, INC. (LUMO)Grant/award (A): 4,500 @ $3.52 · Tax withholding (F): 416 @ $3.52 · Grant/award (A): 35,400 (derivative) @ $0EDGAR
2022-12-154Savara Inc (SVRA)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2022-12-084Savara Inc (SVRA)Option exercise (M): 1,172 @ $0.65 · Option exercise (M): 1,172 (derivative) @ $0EDGAR
2022-09-234LUMOS PHARMA, INC. (LUMO)Purchase (P): 2,214 @ $8.84 · Purchase (P): 208 @ $8.80EDGAR
2022-09-214LUMOS PHARMA, INC. (LUMO)Purchase (P): 541 @ $8.65 · Purchase (P): 1,506 @ $8.75EDGAR
2022-04-054LUMOS PHARMA, INC. (LUMO)Tax withholding (F): 1,466 @ $9.23EDGAR
2022-02-034LUMOS PHARMA, INC. (LUMO)Grant/award (A): 4,500 @ $10.02 · Tax withholding (F): 173 @ $10.02 · Grant/award (A): 35,400 (derivative) @ $0EDGAR
2021-12-144Savara Inc (SVRA)Option exercise (M): 728 @ $0.55 · Option exercise (M): 728 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-114PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 6,336 (derivative) @ $0EDGAR
2021-04-054LUMOS PHARMA, INC. (LUMO)Tax withholding (F): 1,522 @ $12.25EDGAR
2021-02-034LUMOS PHARMA, INC. (LUMO)Grant/award (A): 2,329 @ $0 · Grant/award (A): 28,475 (derivative) @ $0EDGAR
2020-12-174Savara Inc (SVRA)Grant/award (A): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1307632 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs